46 related articles for article (PubMed ID: 26526135)
1. Over-expressed RPL34 promotes malignant proliferation of non-small cell lung cancer cells.
Yang S; Cui J; Yang Y; Liu Z; Yan H; Tang C; Wang H; Qin H; Li X; Li J; Wang W; Huang Y; Gao H
Gene; 2016 Jan; 576(1 Pt 3):421-8. PubMed ID: 26526135
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of MRPL35 promotes cell apoptosis and inhibits cell proliferation in non-small-cell lung cancer.
Zhao C; Chen L; Jin Z; Liu H; Ma C; Zhou H; Xu L; Zhou S; Shi Y; Li W; Chen Y; Dou C; Wang X
BMC Pulm Med; 2023 Dec; 23(1):507. PubMed ID: 38093266
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal protein L34 promotes the proliferation, invasion and metastasis of pancreatic cancer cells.
Wei F; Ding L; Wei Z; Zhang Y; Li Y; Qinghua L; Ma Y; Guo L; Lv G; Liu Y
Oncotarget; 2016 Dec; 7(51):85259-85272. PubMed ID: 27845896
[TBL] [Abstract][Full Text] [Related]
4. Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I.
Yang YJ; Baek JY; Goo J; Shin Y; Park JK; Jang JY; Wang SB; Jeong W; Lee HJ; Um HD; Lee SK; Choi Y; Rhee SG; Chang TS
Antioxid Redox Signal; 2016 Mar; 24(8):453-69. PubMed ID: 26528922
[TBL] [Abstract][Full Text] [Related]
5. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
[TBL] [Abstract][Full Text] [Related]
6. Potential Candidate Genes for Therapeutic Targeting in Chronic Myeloid Leukemia: A Pilot Study.
Alsamman K; Alamri AM; Vatte C; Owaidah AY; Alhassan F; Mubarki R; El-Masry OS
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3077-3085. PubMed ID: 37774059
[TBL] [Abstract][Full Text] [Related]
7. Experimental upregulation of developmentally downregulated ribosomal protein large subunits 7 and 7A promotes axon regeneration after injury in vivo.
Xing J; Theune WC; Lukomska A; Frost MP; Damania A; Trakhtenberg EF
Exp Neurol; 2023 Oct; 368():114510. PubMed ID: 37633482
[TBL] [Abstract][Full Text] [Related]
8. Targeting Oncogene Promoters and Ribosomal RNA Biogenesis by G-Quadruplex Binding Ligands Translate to Anticancer Activity.
Venkata Suseela Y; Sengupta P; Roychowdhury T; Panda S; Talukdar S; Chattopadhyay S; Chatterjee S; Govindaraju T
ACS Bio Med Chem Au; 2022 Apr; 2(2):125-139. PubMed ID: 37101746
[TBL] [Abstract][Full Text] [Related]
9. Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision Medicine.
Saha Detroja T; Detroja R; Mukherjee S; Samson AO
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293493
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of biological mechanisms of artemisinin on bovine mammary epithelial cells by integration of network pharmacology and TMT-based quantitative proteomics.
Tong J; Sun Y; Wang Z; Cui D; Jiang L
Front Pharmacol; 2022; 13():968149. PubMed ID: 36160439
[TBL] [Abstract][Full Text] [Related]
11. Ribosomes: The New Role of Ribosomal Proteins as Natural Antimicrobials.
Hurtado-Rios JJ; Carrasco-Navarro U; Almanza-Pérez JC; Ponce-Alquicira E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012387
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional Profiles Analysis of COVID-19 and Malaria Patients Reveals Potential Biomarkers in Children.
Lambert N; Kengne-Ouafo JA; Rissy WM; Diane U; Murithi K; Kimani P; Awe OI; Dillman A
bioRxiv; 2022 Dec; ():. PubMed ID: 35794887
[TBL] [Abstract][Full Text] [Related]
13. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.
Elhamamsy AR; Metge BJ; Alsheikh HA; Shevde LA; Samant RS
Cancer Res; 2022 Jul; 82(13):2344-2353. PubMed ID: 35303060
[TBL] [Abstract][Full Text] [Related]
14. Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer.
Tsoi H; You CP; Leung MH; Man EPS; Khoo US
Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267559
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of RPL34 suppresses osteosarcoma cell proliferation likely through EIF3/FAU signaling pathway.
Huang P; Zhao J; Fowdur M; Liu Y; Wu H; He M
Transl Cancer Res; 2019 Jun; 8(3):848-855. PubMed ID: 35116824
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of ribosomal proteins in human cancers.
El Khoury W; Nasr Z
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34873618
[TBL] [Abstract][Full Text] [Related]
17. Role of FRG1 in predicting the overall survivability in cancers using multivariate based optimal model.
Khan R; Palo A; Dixit M
Sci Rep; 2021 Nov; 11(1):22505. PubMed ID: 34795329
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.
Kang J; Brajanovski N; Chan KT; Xuan J; Pearson RB; Sanij E
Signal Transduct Target Ther; 2021 Aug; 6(1):323. PubMed ID: 34462428
[TBL] [Abstract][Full Text] [Related]
19. RPL34-AS1-induced RPL34 inhibits cervical cancer cell tumorigenesis via the MDM2-P53 pathway.
Zhu Y; Ren C; Jiang D; Yang L; Chen Y; Li F; Wang B; Zhang Y
Cancer Sci; 2021 May; 112(5):1811-1821. PubMed ID: 33675124
[TBL] [Abstract][Full Text] [Related]
20. Translational Regulation of Cancer Metastasis.
Micalizzi DS; Ebright RY; Haber DA; Maheswaran S
Cancer Res; 2021 Feb; 81(3):517-524. PubMed ID: 33479028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
